Status:
NOT_YET_RECRUITING
Atherosclerotic Cardiovascular Risk in Childhood and Teen-age Onset Diabetes
Lead Sponsor:
Shanghai Jiao Tong University School of Medicine
Conditions:
Atherosclerotic Cardiovascular Disease
Childhood Diabetes Mellitus
Eligibility:
All Genders
18+ years
Brief Summary
For children and adolescents with diabetes, the pathological process of atherosclerotic cardiovascular disease(ASCVD) can exist in early childhood and progress rapidly to subclinical ASCVD. This study...
Detailed Description
Atherosclerotic cardiovascular disease (ASCVD) is the main cause of death in patients with diabetes. Currently recognized ASCVD risk assessment models are limited to adults with diabetes, but for chil...
Eligibility Criteria
Inclusion
- Diagnosis of type 1 diabetes or type 2 diabetes
- Age of onset: \<18y
- Enrollment age: ≥18y
- Gender: male or female
- Diabetes duration ≥ 5 years
Exclusion
- Specific types of diabetes
- Clinical diagnosis of diabetes is unknown, and it belongs to untyped diabetes
- Pregnancy or lactation
- Received glucocorticoids, immunosuppressants, non-glycemic biological agents, and cytotoxic drugs in the past 3 months; non-steroidal pain relievers or antibiotics used for more than 1 week continuously
- Onset of acute complications of diabetes in the past 3 months
- Major trauma and surgery history in the past 3 months
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2027
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05294653
Start Date
June 1 2022
End Date
January 1 2027
Last Update
May 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Endocrinology and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao-Tong University
Shanghai, China, 200025